RPG Life Sciences (RPGLIFE) | Stock Overview & Key Data
RPG Life Sciences Performance Comparison
Stock Range
Today's Range
Low: ₹2,254.80
High: ₹2,329.90
on August 18, 2025
52 Week Range
Low: ₹1,835.00
High: ₹2,974.95
on April 7, 2025
on October 15, 2024
All-Time High: ₹2,974.95 on October 14, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR37.4B
EPS
110.42
P/E Ratio (TTM)
20.49
Forward P/E
79.17
P/B Ratio
7.05
PEG Ratio
-11.84
Div. Yield
1.50%
ROE
34.54%
Beta
-0.365
Debt to Equity
0.00
Financial Highlights
Profitability
Gross Margin
64.47%
Operating Margin
17.95%
Profit Margin
27.82%
Returns and Earnings
Return on Assets (TTM)
27.86%
Return on Equity (TTM)
34.54%
EBITDA
INR1.6B
Net Income (TTM)
INR1.8B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR397.20
Quarterly Revenue Growth (YoY)
2.10%
Quarterly Earnings Growth (YoY)
-1.80%
Dividend Information
Last 12-Month Dividend
₹36.00
Current Dividend Yield
1.50%
3-Year Average Dividend Yield
1.17%
3-Year Average Annual Dividend
₹19.20
3-Year Total Dividends
₹57.60
Ex-Dividend Date
June 27, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| RPG Life Sciences RPGLIFE | 37.42B Small-cap | -0.78% | -9.25% | 4.86% | 0.95% | 3.01% | 8.11% | 219.27% | 491.17% |
| Sun Pharmaceutical SUNPHARMA | 3.94T Large-cap | 2.69% | -2.45% | -3.91% | -3.48% | -13.15% | -5.82% | 82.10% | 208.33% |
| Divi's Laboratories DIVISLAB | 1.63T Large-cap | 0.02% | -9.53% | -1.34% | 4.94% | 0.98% | 32.34% | 65.91% | 88.85% |
| Sun Pharma Advanced SPARC | 45.51B Small-cap | -3.92% | -13.01% | -6.93% | -0.76% | -30.12% | -34.25% | -41.92% | -22.97% |
| Aarti Drugs AARTIDRUGS | 44.42B Small-cap | -3.86% | 1.23% | 5.23% | 18.26% | 6.84% | -2.04% | 8.97% | -37.88% |
| Sequent Scientific SEQUENT | 43.92B Small-cap | 0.45% | -5.27% | 0.82% | 19.96% | -4.81% | 22.66% | 59.79% | 34.23% |
Ownership & Short Interest
Insider Ownership
70.87%
Institutional Ownership
9.04%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
10K
Average 90-Day Volume
30K
RPG Life Sciences Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in RPG Life Sciences would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is RPGLIFE's 52-week high and low?
- In the last 52 weeks, RPG Life Sciences reached a high of ₹2,974.95 (on October 15, 2024) and a low of ₹1,835.00 (on April 7, 2025).
- What is the market cap and P/E ratio for RPGLIFE?
- Curious about RPG Life Sciences's size and valuation? Its market capitalization stands at 37.42B. When it comes to valuation, the P/E ratio (trailing twelve months) is 20.49, and the forward P/E (looking ahead) is 79.17.
- Does RPGLIFE pay dividends? If so, what's the yield?
- Yes, RPG Life Sciences is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.50%, and the company has paid an average of ₹19.20 per share annually over the past 3 years.
- Who are RPG Life Sciences's main competitors or similar companies to consider before investing?
When looking at RPG Life Sciences, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.94T Healthcare Drug Manufacturers - Specialty & Generic -5.82% 82.10% Divi's Laboratories
DIVISLAB1.63T Healthcare Drug Manufacturers - Specialty & Generic 32.34% 65.91% Sun Pharma Advanced
SPARC45.51B Healthcare Drug Manufacturers - Specialty & Generic -34.25% -41.92% Aarti Drugs
AARTIDRUGS44.42B Healthcare Drug Manufacturers - Specialty & Generic -2.04% 8.97% Sequent Scientific
SEQUENT43.92B Healthcare Drug Manufacturers - Specialty & Generic 22.66% 59.79% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for RPG Life Sciences Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of RPG Life Sciences's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 34.54%, the Debt to Equity ratio from the most recent quarter is 0.00, and its Gross Profit Margin stands at 64.47%.
- What is the recent revenue and earnings growth for RPGLIFE?
- Looking at RPG Life Sciences's growth, its revenue over the trailing twelve months (TTM) was INR7B. Compared to the same quarter last year (YoY), quarterly revenue grew by 2.10%, and quarterly earnings saw a YoY growth of -1.80%.
- How much of RPGLIFE stock is held by insiders and institutions?
- Wondering who owns RPG Life Sciences stock? Company insiders (like executives and directors) hold about 70.87% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 9.04%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.